Although the relationship between cancer biology and the systemic response of the body is complex, this relationship is founded on the hypothesis postulating that inflammatory cytokines (IL-1, IL-6, IL-8 and interferon-γ) released by the tumor trigger circulating acute phase reactants and hematological components including serum neutrophil counts [19]. The gene discussed is IL6; the disease is cancer.